These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 24041901)
1. Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni. Ziniel PD; Desai J; Cass CL; Gatto C; Oldfield E; Williams DL Antimicrob Agents Chemother; 2013 Dec; 57(12):5969-76. PubMed ID: 24041901 [TBL] [Abstract][Full Text] [Related]
2. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates. Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent Farnesyl Diphosphate Analogue: A Probe To Validate trans-Prenyltransferase Inhibitors. Teng KH; Hsu ET; Chang YH; Lin SW; Liang PH Biochemistry; 2016 Aug; 55(31):4366-74. PubMed ID: 27428767 [TBL] [Abstract][Full Text] [Related]
5. Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. Zhang Y; Cao R; Yin F; Hudock MP; Guo RT; Krysiak K; Mukherjee S; Gao YG; Robinson H; Song Y; No JH; Bergan K; Leon A; Cass L; Goddard A; Chang TK; Lin FY; Van Beek E; Papapoulos S; Wang AH; Kubo T; Ochi M; Mukkamala D; Oldfield E J Am Chem Soc; 2009 Apr; 131(14):5153-62. PubMed ID: 19309137 [TBL] [Abstract][Full Text] [Related]
6. Specific Inhibition of the Bifunctional Farnesyl/Geranylgeranyl Diphosphate Synthase in Malaria Parasites via a New Small-Molecule Binding Site. Gisselberg JE; Herrera Z; Orchard LM; Llinás M; Yeh E Cell Chem Biol; 2018 Feb; 25(2):185-193.e5. PubMed ID: 29276048 [TBL] [Abstract][Full Text] [Related]
7. Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis. Sharma A; Sharma M; Yogavel M; Sharma A PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005084. PubMed ID: 27806050 [TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates. Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508 [TBL] [Abstract][Full Text] [Related]
9. Large-scale RNAi screening uncovers therapeutic targets in the parasite Wang J; Paz C; Padalino G; Coghlan A; Lu Z; Gradinaru I; Collins JNR; Berriman M; Hoffmann KF; Collins JJ Science; 2020 Sep; 369(6511):1649-1653. PubMed ID: 32973031 [TBL] [Abstract][Full Text] [Related]
10. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni. Sanchez MC; Cupit PM; Bu L; Cunningham C Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180 [TBL] [Abstract][Full Text] [Related]
11. Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery. Zafar A; Ahmad S; Rizvi A; Ahmad M PLoS One; 2015; 10(5):e0123996. PubMed ID: 25933436 [TBL] [Abstract][Full Text] [Related]
12. Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase. Rodriguez JB; Falcone BN; Szajnman SH Expert Opin Drug Discov; 2016; 11(3):307-20. PubMed ID: 26781029 [TBL] [Abstract][Full Text] [Related]